Quick Order Cart

Cat. No. ARG2081

GNG10 Knockout AGS Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Stomach

  • Disease:

    Adenocarcinoma

The GNG10 Knockout AGS Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of human gastric adenocarcinoma AGS cells, disrupting the G protein gamma-10 subunit. GNG10 forms the G?¦? dimer with GNB1/2 and regulates effectors like PLC??3 and PI3K, modulating MAPK/ERK and Wnt/??-catenin signaling. This model aids in studying GNG10??s role in gastric cancer progression, metastasis, and H. pylori pathogenesis, with applications including GPCR signaling analysis, Wnt pathway reporter assays, and anti-metastatic drug screening using Transwell invasion assays, Western blotting, and intracellular calcium imaging.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    AGS

    Sex of Donor

    Female

    Age

    54 years

    Derived From Site

    In situ; Stomach

    Gene Name

    GNG10

    Gene Identifier

    NCBI Gene ID 2790

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    Ham's F-12

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The GNG10 Knockout AGS Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout population derived from the human gastric adenocarcinoma cell line AGS, providing a loss-of-function model for the G protein gamma-10 subunit gene (GNG10). This population undergoes targeted disruption of GNG10, enabling researchers to investigate the functional consequences of GNG10 ablation in a gastric epithelial context relevant to cancer biology and GPCR signaling.

The AGS cell line, isolated from a primary human gastric adenocarcinoma, is an adherent epithelial model widely utilized in gastric cancer research and Helicobacter pylori infection studies. These cells retain key characteristics of gastric mucosal epithelium and serve as a neoplastic transformation platform, making them suitable for examining oncogenic signaling mechanisms, tumor suppressor functions, and host-pathogen interactions that contribute to gastric malignancy.

GNG10 encodes the gamma subunit of heterotrimeric G proteins, which forms a stable complex with G?? subunits (e.g., GNB1, GNB2) to create the G?¦? dimer upon GPCR activation. This dimer directly interacts with and regulates downstream effectors such as PLC??3 and adenylyl cyclase, modulating calcium and cAMP levels. G?¦? also activates PI3K, leading to Akt phosphorylation, and couples to the MAPK/ERK pathway via receptor tyrosine kinase transactivation by EGF. In AGS cells, GNG10 expression is influenced by Wnt ligands and the ??-catenin/TCF complex, which may transcriptionally regulate GNG10, while TNF and H. pylori CagA further modulate its expression. GNG10-containing G?¦? dimers also intersect with Wnt/??-catenin signaling; GNG10 knockout likely attenuates ??-catenin activity, reducing cyclin D1, c-Myc, and MMP-9 expression, and altering GRK2 interactions. These molecular connections underscore GNG10??s integration of GPCR-initiated and Wnt signals to control proliferation and motility.

In the AGS gastric adenocarcinoma environment, disruption of GNG10 is expected to impair GPCR-driven proliferative and migratory signals, particularly through dampened PI3K-Akt and MAPK/ERK pathway activation, while concomitantly suppressing Wnt/??-catenin-dependent transcription. This may attenuate oncogenic phenotypes such as anchorage-independent growth, invasion, and metastasis, mirroring studies where G protein ?? subunits contribute to gastrointestinal tumor progression. The model provides a valuable tool to dissect the contribution of G?¦?-mediated signaling to H. pylori CagA-induced cellular transformation, as CagA has been shown to modulate ??-catenin and MAPK pathways in AGS cells.

Typical applications of these polyclonal knockout cells include detailed characterization of GPCR signaling cascades, Wnt/??-catenin pathway interrogation using TOP/FOP flash reporter assays, and evaluation of metastatic potential via Transwell invasion and wound healing migration assays. They also serve in anti-metastatic drug screening and G protein-targeted therapy development, with validation by Western blotting, RT-qPCR, cAMP ELISA, and intracellular calcium imaging. Their polyclonal nature ensures population-level analysis suited to functional genomic screening and bulk assays. For further information or custom requests, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)